In This Section

Precision Medicine Strategies for Treating Cardiovascular Disease

Tuesday April 07, 2020

8:00 am - 10:00 am Eastern Time (ET)

Room 15 B


Chair :

Hemal Patel
University of California, San Diego

Eric Gross
Stanford University

During this symposium, we will discuss strategies based on omics to develop precision medicine for cardiovascular disease. The topic is timely since the integration of omics into medical treatment and care is occurring at a rapid pace. Topics include describing how different omics data (genomic, metabolomic and exosomic) can lay the groundwork for developing precision medicine.


Che-Hong Chen - Stanford University

Leveraging Genetics to Develop Drugs, Such as Alda-1, to Treat Cardiovascular Disease

Isabella Kilanowski-Doroh - Tulane University School of Medicine

Impact of GPER, Sex, and Age on Arterial Stiffness and Fibrotic Gene Expression

David Roth - University of California, San Diego

The Exosome as an -Omics Tool to Developing Precision Medicine for Cardiac Injury and Repair

Sarah Jimenez MacInnes - MyoKardia

Precision Cardiovascular Medicine for Genetically Driven Cardiomyopathies

Kyle LaPenna - LSU Health Sciences Center

Development and Characterization of a Novel Small Animal Model of Heart Failure with Preserved Ejection Fraction

Brinda Rana - University of California, San Diego

The NASA Twins Study: What Space Flight can Reveal about Cardiovascular Metabolomics

Panel Discussion

Last Updated: December 10, 2020
Key Dates
March 6

Housing discounts end

March 13

Advance Registration Ends

April 3-4

GPCR Colloquium (separate ticket required)

April 4

ASPET Business Meeting and Awards Presentation

April 4-7

ASPET Annual Meeting at EB 2020

Thank you to our Annual Meeting partners:

University of Kentucky
Icahn School
University of Georgia
University of Minnesota
WSU Pharm-Pharm Sciences Unit
PR & P